Back to top

CVS Health price target raised to $107 from $94 at Baird

Baird analyst Michael Ha raised the firm’s price target on CVS Health (CVS) to $107 from $94 and keeps an Outperform rating on the shares. Publishe...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CVS Health Corporation (CVS)